The U.S. Centers for Medicare and Medicaid Services (CMS) said on Wednesday that it would seek “greater transparency” in drug price negotiations under President Donald Trump’s administration. The statement follows criticism from the pharmaceutical industry regarding the program.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( The Trump administration promises 'greater transparency' in drug price negotiations )
Also on site :
- Trump economic advisor confident in China trade deal conclusion on Monday
- Men have hundreds more saved in ‘rainy day’ funds than women, research indicates
- Trump announces U.S.-China trade talks in London